Weller M - Search Results

1

Radiochemotherapy of malignant glioma in adults. Clinical experiences.

Kortmann RD, Jeremic B, Weller M, Plasswilm L, Bamberg M. Kortmann RD, et al. Among authors: weller m. Strahlenther Onkol. 2003 Apr;179(4):219-32. doi: 10.1007/s00066-003-1027-y. Strahlenther Onkol. 2003. PMID: 12707711 Review.

2

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

Roth W, Fontana A, Trepel M, Reed JC, Dichgans J, Weller M. Roth W, et al. Among authors: weller m. Cancer Immunol Immunother. 1997 Mar;44(1):55-63. doi: 10.1007/s002620050355. Cancer Immunol Immunother. 1997. PMID: 9111585 Free PMC article.

3

Potentiation of treosulfan toxicity by the glutathione-depleting agent buthionine sulfoximine in human malignant glioma cells: the role of bcl-2.

Reber U, Wüllner U, Trepel M, Baumgart J, Seyfried J, Klockgether T, Dichgans J, Weller M. Reber U, et al. Among authors: weller m. Biochem Pharmacol. 1998 Feb 1;55(3):349-59. doi: 10.1016/s0006-2952(97)00480-2. Biochem Pharmacol. 1998. PMID: 9484802

4

Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells.

Ständer M, Dichgans J, Weller M. Ständer M, et al. Among authors: weller m. J Neurooncol. 1998 May;37(3):191-8. doi: 10.1023/a:1005870122744. J Neurooncol. 1998. PMID: 9524077

5

CD95 ligand: lethal weapon against malignant glioma?

Weller M, Kleihues P, Dichgans J, Ohgaki H. Weller M, et al. Brain Pathol. 1998 Apr;8(2):285-93. doi: 10.1111/j.1750-3639.1998.tb00154.x. Brain Pathol. 1998. PMID: 9546287 Free PMC article. Review.

6

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.

Rieger L, Weller M, Bornemann A, Schabet M, Dichgans J, Meyermann R. Rieger L, et al. Among authors: weller m. J Neurol Sci. 1998 Feb 18;155(1):68-75. doi: 10.1016/s0022-510x(97)00277-3. J Neurol Sci. 1998. PMID: 9562325

7

Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.

Trepel M, Groscurth P, Malipiero U, Gulbins E, Dichgans J, Weller M. Trepel M, et al. Among authors: weller m. J Neurooncol. 1998 Aug;39(1):19-32. doi: 10.1023/a:1005910323338. J Neurooncol. 1998. PMID: 9760067

8

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

Weller M, Rieger J, Grimmel C, Van Meir EG, De Tribolet N, Krajewski S, Reed JC, von Deimling A, Dichgans J. Weller M, et al. Int J Cancer. 1998 Dec 18;79(6):640-4. doi: 10.1002/(sici)1097-0215(19981218)79:6<640::aid-ijc15>3.0.co;2-z. Int J Cancer. 1998. PMID: 9842975

9

Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells.

Roller A, Weller M. Roller A, et al. Among authors: weller m. Anticancer Res. 1998 Nov-Dec;18(6A):4493-7. Anticancer Res. 1998. PMID: 9891515

10

Topotecan-based combination chemotherapy for human malignant glioma.

Schmidt F, Schuster M, Streffer J, Schabet M, Weller M. Schmidt F, et al. Among authors: weller m. Anticancer Res. 1999 Mar-Apr;19(2A):1217-21. Anticancer Res. 1999. PMID: 10368678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,703 results

Search Page

Filters